TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

NCT07510191 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

312

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease (CD)

Interventions

DRUG: Upadacitinib
DRUG: Infliximab Dose Intensification
DRUG: Adalimumab Dose Intensification
DRUG: Standard-Dose infliximab
DRUG: Standard-Dose Adalimumab

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University